---
noindex: true
sitemap: false
layout: default
title: Alpha-Tocopherol
parent: Low Evidence (L5)
nav_order: 68
evidence_level: L5
indication_count: 0
last_modified_at: 2026-11-12
predicted_indications: []
---

# Alpha-Tocopherol
{: .fs-9 }

Evidence Level: **L5** | Predicted Indications: **0** 
{: .fs-6 .fw-300 }

---

## Table of Contents
{: .no_toc .text-delta }

1. TOC
{:toc}

---

<div id="pharmacist" markdown="1">

## Pharmacist Assessment Report

</div>

## Alpha-Tocopherol: Insufficient Data to Complete Drug Repurposing Assessment
{: .text-alpha }

## One-Sentence Summary

Alpha-tocopherol, the primary bioactive form of vitamin E, is a fat-soluble antioxidant widely present in foods and supplements.
In this Evidence Pack, **the TxGNN model generated no novel indication predictions**. The assessment workflow cannot be initiated due to missing core data; it is recommended to complete the data first and then re-execute.

<!-- review:begin sg-lic-20261106-alpha-tocopherol-1 -->

> **Review correction (2026-11-06)**: Originally stated: "In this Evidence Pack, **the TxGNN model generated no novel indication predictions**, and there are no registration data in the Singapore market or safety data." Removed: it conflicted with the HSA register data (the HSA register of therapeutic products as of 2026-11-06). The HSA register lists 1 registration for this drug, 1 current; the Quick Overview and the table under Singapore Market Information show the current figures. Source: [HSA – Listing of registered therapeutic products (data.gov.sg)](https://data.gov.sg/).

<!-- review:end sg-lic-20261106-alpha-tocopherol-1 -->

---

## Quick Overview

| Item | Content |
|------|---------|
| Original Indication | None |
| Predicted New Indication | None (TxGNN produced no predictions) |
| TxGNN Prediction Score | None |
| Evidence Level | Cannot be determined (no prediction data) |
| Singapore Market Status | Marketed (valid licences: 1 of 1) |
| Number of Registrations | 1 (valid: 1) |
| Recommended Decision | Hold |

---

## Why Can't This Evaluation Proceed?

Alpha-tocopherol is the most biologically active isoform of vitamin E, functioning primarily as a lipophilic free radical scavenger that exerts antioxidant effects to protect cell membranes from peroxidative damage. According to existing pharmacological knowledge, its applications span research directions including vitamin E deficiency, neuroprotection, and cardiovascular support.

However, this Evidence Pack has fundamental gaps:

<!-- review:begin sg-lic-20261106-alpha-tocopherol-2 -->

> **Review correction (2026-11-06)**: Originally stated: "However, this Evidence Pack has three fundamental gaps:" Removed: it conflicted with the HSA register data (the HSA register of therapeutic products as of 2026-11-06). The HSA register lists 1 registration for this drug, 1 current; the Quick Overview and the table under Singapore Market Information show the current figures. Source: [HSA – Listing of registered therapeutic products (data.gov.sg)](https://data.gov.sg/).

<!-- review:end sg-lic-20261106-alpha-tocopherol-2 -->

1. **No TxGNN prediction results**: the `predicted_indications` array is empty, the core input for drug repurposing assessment does not exist, and subsequent mechanism-of-action correlation analysis, clinical trial matching, and literature evidence cannot be conducted.
3. **Complete lack of safety data**: warnings, contraindications, and drug interactions have no data, DG001 has been flagged as **Blocking** level, and per assessment workflow rules, the preliminary safety evaluation has not passed and should not proceed to indication recommendation stage.

<!-- review:begin sg-lic-20261106-alpha-tocopherol-3 -->

> **Review correction (2026-11-06)**: Originally stated: "**No TxGNN prediction results**: the `predicted_indications` array is empty, the core input for drug repurposing assessment does not exist, and subsequent mechanism-of-action correlation analysis, clinical trial matching, and literature evidence cannot be conducted. / **No Singapore market registration**: `total_licenses = 0`, unable to confirm approved indications or current therapeutic positioning, Quick Overview table has no original indications to populate." Removed: the number or status of product registrations stated here did not match the HSA register data (the HSA register of therapeutic products as of 2026-11-06). The HSA register lists 1 registration for this drug, 1 current; the Quick Overview and the table under Singapore Market Information show the current figures. Source: [HSA – Listing of registered therapeutic products (data.gov.sg)](https://data.gov.sg/).

<!-- review:end sg-lic-20261106-alpha-tocopherol-3 -->

---

## Conclusion and Next Steps

**Decision: Hold**

**Rationale:**
TxGNN generated no predicted candidate indications, and the safety data gap has been flagged as Blocking level; the existing information is insufficient to support any recommendation decision.

**To proceed, the following is needed:**

- **Confirm DrugBank ID mapping**: Query DrugBank to confirm the correct DrugBank ID for ALPHA-TOCOPHEROL, and ensure the drug node exists in the TxGNN knowledge graph
- **Re-run TxGNN prediction**: using the correct DrugBank ID, re-execute the prediction workflow to generate `predicted_indications` data
- **Supplement mechanism of action (MOA)**: Obtain detailed mechanism descriptions via DrugBank API (DG002, High priority)
- **Download package insert and extract safety data**: Obtain warnings and contraindications (DG001, Blocking priority); assessment workflow can proceed only after passing preliminary safety evaluation

<!-- review:begin sg-lic-20261106-alpha-tocopherol-4 -->

> **Review correction (2026-11-06)**: Originally stated: "**Re-run TxGNN prediction**: using the correct DrugBank ID, re-execute the prediction workflow to generate `predicted_indications` data / **Obtain Singapore HSA registration data**: Query the HSA drug database ([https://eservice.hsa.gov.sg/](https://eservice.hsa.gov.sg/)) to confirm whether there are products registered under the ingredient names "tocopherol" or "vitamin E"" Removed: it conflicted with the HSA register data (the HSA register of therapeutic products as of 2026-11-06). The HSA register lists 1 registration for this drug, 1 current; the Quick Overview and the table under Singapore Market Information show the current figures. Source: [HSA – Listing of registered therapeutic products (data.gov.sg)](https://data.gov.sg/).

<!-- review:end sg-lic-20261106-alpha-tocopherol-4 -->

<!-- review:begin log -->

## Review Log

Below is the review log for this page: statements checked against official Health Sciences Authority data (the register of therapeutic products). Corrections are limited to basic factual statements; model predictions, evidence levels, and conclusions were not rewritten.

| Review date | Item | Action | Source |
|------|------|------|------|
| 2026-11-06 | Removed: "and there are no registration data in the Singapore market or safety data" | Corrected | [HSA – Listing of registered therapeutic products (data.gov.sg)](https://data.gov.sg/) |
| 2026-11-06 | Removed: "three" | Corrected | [HSA – Listing of registered therapeutic products (data.gov.sg)](https://data.gov.sg/) |
| 2026-11-06 | Removed: "2. **No Singapore market registration**: `total_licenses = 0`, unable to confirm approved indications or current therapeutic positioning, Qu" | Corrected | [HSA – Listing of registered therapeutic products (data.gov.sg)](https://data.gov.sg/) |
| 2026-11-06 | Removed: "**Obtain Singapore HSA registration data**: Query the HSA drug database ([https://eservice.hsa.gov.sg/](https://eservice.hsa.gov.sg/)) to co" | Corrected | [HSA – Listing of registered therapeutic products (data.gov.sg)](https://data.gov.sg/) |

<!-- review:end log -->

## Disclaimer

This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.

---

